Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply.

Lancet Diabetes Endocrinol · 2022 · PMC8673873 · PMID 34921753

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The number of kidney events was numerically lower in patients who received dapagliflozin across all these endpoints, although these findings did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.